Cargando…

A randomized, double-blind, placebo-controlled trial investigating cholesterol-lowering effects and safety of yellow yeast rice in adults with mild to moderate hypercholesterolemia: A study protocol

BACKGROUND: Elevated levels of blood lipids are well-documented risk factors for cardiovascular disease. For cardiovascular risk reduction, preventive strategies to lower blood cholesterol levels are essential, and these strategies include lifestyle modification and cholesterol-lowering agents. We a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Sewon, Lee, Jaekyung, Kwon, Oran, Kim, Ji Won, Oh, Bumjo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078669/ https://www.ncbi.nlm.nih.gov/pubmed/30045307 http://dx.doi.org/10.1097/MD.0000000000011634

Ejemplares similares

Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial
por: Verhoeven, Veronique, et al.
Publicado: (2013)

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study
por: Gonnelli, Stefano, et al.
Publicado: (2014)

Cholesterol lowering attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia
por: Muthuramu, Ilayaraja, et al.
Publicado: (2019)

Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
por: Cicolari, Stefania, et al.
Publicado: (2021)

LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
por: Magno, S., et al.
Publicado: (2018)

Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia
por: Weidner, Christina, et al.
Publicado: (2008)

Effectiveness of a Novel Nutraceutical Compound Containing Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects With Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study
por: Cimaglia, Paolo, et al.
Publicado: (2019)

Antioxidative and Cholesterol-Lowering Effects of Lemon Essential Oil in Hypercholesterolemia-Induced Rabbits
por: Lee, Hyunjoo, et al.
Publicado: (2018)

P02.88. Powdered Red Yeast Rice and Plant Stanols and Sterols to lower cholesterol
por: Feuerstein, J, et al.
Publicado: (2012)

Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: a double-blinded, randomized, placebo-controlled study
por: Ryu, Na Hee, et al.
Publicado: (2014)

A dietary cholesterol challenge study to assess Chlorella supplementation in maintaining healthy lipid levels in adults: a double-blinded, randomized, placebo-controlled study
por: Kim, Sangmi, et al.
Publicado: (2016)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

Low-Fat Nondairy Minidrink Containing Plant Stanol Ester Effectively Reduces LDL Cholesterol in Subjects with Mild to Moderate Hypercholesterolemia as Part of a Western Diet
por: Hallikainen, Maarit, et al.
Publicado: (2013)

Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy
por: Vuorio, Alpo, et al.
Publicado: (2022)

Associations of Diet Quality and Sleep Quality with Obesity
por: Hur, Soohee, et al.
Publicado: (2021)

Homozygous familial hypercholesterolemia with an update on cholesterol management
por: Velvet, Anju J J, et al.
Publicado: (2020)

A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
por: Rossignol, Jean-François, et al.
Publicado: (2022)

Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia
por: Riva, Antonella, et al.
Publicado: (2021)

NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease
por: Lawlor, Brian, et al.
Publicado: (2014)

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study
por: Spigoni, Valentina, et al.
Publicado: (2017)

Safety and Effects of Lactobacillus paracasei TISTR 2593 Supplementation on Improving Cholesterol Metabolism and Atherosclerosis-Related Parameters in Subjects with Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Khongrum, Jurairat, et al.
Publicado: (2023)

Evaluation of the Cholesterol-Lowering Mechanism of Enterococcus faecium Strain 132 and Lactobacillus paracasei Strain 201 in Hypercholesterolemia Rats
por: Yang, Lingshuang, et al.
Publicado: (2021)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Serum MIG6 concentration is increased by cholesterol-lowering treatment in patients with type 2 diabetes mellitus and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial
por: Buyuktuncer, Zehra, et al.
Publicado: (2013)

LDL cholesterol-lowering effect of Daeshiho-tang in patients with dyslipidemia: A pilot randomized, double-blind, placebo-controlled trial
por: Noh, Ji-Won, et al.
Publicado: (2023)

Efficacy of yogurt drink with added plant stanol esters (Benecol(®), Colanta) in reducing total and LDL cholesterol in subjects with moderate hypercholesterolemia: a randomized placebo-controlled crossover trial NCT01461798
por: Vásquez-Trespalacios, Elsa M, et al.
Publicado: (2014)

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk
por: Figorilli, Filippo, et al.
Publicado: (2022)

Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
por: Aisen, Paul S., et al.
Publicado: (2011)

Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
por: Dorostkar, Azadeh, et al.
Publicado: (2021)

The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial
por: Yargholi, Alireza, et al.
Publicado: (2021)

Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
por: Manomaipiboon, Anan, et al.
Publicado: (2022)

Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
por: McGowan, Mary P., et al.
Publicado: (2012)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism
por: Mosig, Sandy, et al.
Publicado: (2008)

Familial hypercholesterolemia with bilateral cholesterol granuloma: A case series
por: Albakheet, Nouf, et al.
Publicado: (2019)

Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice
por: Gaillard, Dany, et al.
Publicado: (2021)

Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction
por: Fancher, Ibra S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4i8ee5d8pt6ugpm4nscb569v6r